Hematopoietic stem cell-derived myeloid and plasmacytoid DC-based vaccines are highly potent inducers of tumor-reactive T cell and NK cell responses ex vivo

por Thordardottir, Soley, Schaap, Nicolaas, Louer, Elja, Kester, Michel G. D., Falkenburg, J. H. Frederik, Jansen, Joop, Radstake, Timothy R. D., Hobo, Willemijn, Dolstra, Harry
Publicado 2017

Natural Polymorphisms in Tap2 Influence Negative Selection and CD4∶CD8 Lineage Commitment in the Rat

por Tuncel, Jonatan, Haag, Sabrina, Yau, Anthony C. Y., Norin, Ulrika, Baud, Amelie, Lönnblom, Erik, Maratou, Klio, Ytterberg, A. Jimmy, Ekman, Diana, Thordardottir, Soley, Johannesson, Martina, Gillett, Alan, Stridh, Pernilla, Jagodic, Maja, Olsson, Tomas, Fernández-Teruel, Alberto, Zubarev, Roman A., Mott, Richard, Aitman, Timothy J., Flint, Jonathan, Holmdahl, Rikard
Publicado 2014

Clinically applicable CD34(+)-derived blood dendritic cell subsets exhibit key subset-specific features and potently boost anti-tumor T and NK cell responses

por van Eck van der Sluijs, Jesper, van Ens, Diede, Thordardottir, Soley, Vodegel, Denise, Hermens, Inge, van der Waart, Anniek B., Falkenburg, J. H. Frederik, Kester, Michel G. D., de Rink, Iris, Heemskerk, Mirjam H. M., Borst, Jannie, Schaap, Nicolaas P. M., Jansen, Joop H., Xiao, Yanling, Dolstra, Harry, Hobo, Willemijn
Publicado 2021